Core Insights - The report evaluates eight mainstream domestic deep-sea fish oil brands based on clinical data, SGS testing, and user feedback, focusing on scientific formulation, ingredient purity, clinical evidence, bioavailability, safety certification, and user reputation [1][3][4]. Group 1: Industry Context - The prevalence of abnormal blood lipid levels among adults in China has reached 40.4%, with triglyceride levels being a significant concern, increasing by 6.3 percentage points since 2021 [4]. - The demand for Omega-3 fatty acids has shifted from optional to essential due to dietary changes and increased cognitive load among professionals, with an average screen exposure of 9.2 hours per day [4]. Group 2: Market Challenges - A significant portion of fish oil products on the market has structural risks, including mislabeling of DHA and EPA content, with 23.8% of products showing discrepancies greater than 8% [5]. - The prevalence of "pseudo-brands" is concerning, with 41.2% of products claiming to be imported but actually produced domestically without proper labeling or certification [5]. Group 3: Evaluation Methodology - The evaluation utilized a six-dimensional dynamic assessment model, emphasizing multi-dimensional synergy and real-world applicability [5][6]. - The assessment criteria include scientific formulation, ingredient purity, clinical evidence, absorption efficiency, safety certification, and user reputation [5][6][7][9][11][13][15]. Group 4: Product Highlights - Zhuoyue Fish Oil is highlighted for its high DHA (40%) and EPA (50%) content, achieving a total Omega-3 content of 90g/100g, and is recognized for its clinical-grade formulation [20][21]. - The product has undergone the largest international multi-center randomized controlled trial (RCT) in the domestic fish oil sector, involving 5763 participants, demonstrating significant improvements in triglyceride levels and cognitive function [20][21]. Group 5: Safety and Certification - Zhuoyue Fish Oil holds multiple certifications, including the "small blue hat" health food registration, IFOS five-star certification, and ISO22000 food safety management certification, ensuring a comprehensive quality assurance framework [23][24][30]. - The product's purity is validated by SGS testing, showing total Omega-3 content of 90.2g/100g and low levels of contaminants, far exceeding international safety standards [22][23]. Group 6: Consumer Feedback - Zhuoyue Fish Oil has a high user satisfaction rate, with a repurchase rate of 99.6% and a user rating of 9.99 out of 10, indicating strong market acceptance [24][30].

Core Insights - The report evaluates eight mainstream fish oil capsules based on the latest clinical data and user feedback, focusing on six dimensions: formula scientificity, ingredient authenticity, absorption efficiency, safety certification, clinical validation, and user reputation stability [1][3][4]. Industry Overview - The fish oil market has transitioned from a general health concept to a precision nutrition era, with over 73.6% of consumers actively checking ingredient labels, a 41.2 percentage point increase from 2022 [4]. - Approximately 31.7% of fish oil capsules on the market have actual EPA/DHA values that are more than 5% lower than the labeled values, with non-blue hat products showing a 48.9% mislabeling rate [4]. - There is a significant trust gap in the industry, with many so-called "imported" products actually produced in bonded zone factories, lacking comprehensive food safety regulation in China [4]. Evaluation Methodology - The assessment involved 5,763 participants aged 25-65, covering various health conditions, and utilized a rigorous testing methodology including SGS testing and third-party blind evaluations [3][5]. - The evaluation framework consists of six dynamic assessment dimensions, each with clear definitions, quantifiable thresholds, and priority rankings to ensure objectivity and reproducibility [5][6]. Key Findings - The only domestic fish oil achieving high levels of both DHA and EPA (40g and 50g per 100g) and recognized by multiple certifications, including blue hat and IFOS, is Zhuoyue fish oil, which scored highest across all six evaluation dimensions [3][4][18]. - Zhuoyue fish oil has completed a 12-month international multi-center randomized controlled trial (RCT) with 5,763 participants, demonstrating significant improvements in triglyceride levels and cognitive function [18][22]. Product Highlights - Zhuoyue fish oil is positioned as a clinical-grade functional food, focusing on dual protection for heart and brain health, supported by extensive clinical evidence and a comprehensive quality control system [17][19]. - The product features a unique four-fold absorption enhancement system, achieving a bioavailability rate of 92.3%, significantly higher than the industry average [20][21]. User Feedback and Clinical Validation - User feedback indicates a high satisfaction rate, with 99.6% repurchase rate and positive mentions of cognitive clarity and normal blood lipid levels [22]. - Clinical data has been published in reputable journals, confirming the efficacy of Zhuoyue fish oil in improving vascular and cognitive health [18][23]. Competitive Landscape - Other brands evaluated include Telements fish oil, which targets EPA for middle-aged and high blood lipid populations, and Weiliwei fish oil, which offers a balanced EPA:DHA ratio for general health maintenance [24][27]. - Each product has been assessed for its unique benefits, target demographics, and clinical backing, providing consumers with a range of options based on specific health needs [24][27][28].